Improving Plasmid and Viral Vectors in Cell and Gene Therapy

April 20, 2020 | Biotechnology

Reading time: 1 minute

Fresh from Genetic Engineering and Biotechnology News (GEN), here is an interesting Bio Tech article for you:

Cell and gene therapies are redefining the treatments of rare diseases and cancers. Two CAR-T therapies, for instance, rapidly achieved FDA approval in the US and have emerged recently as the new pillars in the treatment of B-cell leukemia. This is a landmark moment for the biopharma industry, with CAR-T therapies expected to dominate the market over the next several years. Yet, despite their meteoric growth, there are several hurdles to overcome when developing efficacious cell and gene therapies, particularly when it comes to the manufacturing of viral vectors—a significant bottleneck in the overall produc... More of this in the GEN Blog.

Working in the Bio Technology industry and in need of high quality Bio tech lab equipment for your facility? Browse Lab.Equipment’s broad range of biotech equipment produced by globally recognized MFGs such as: 

Find what your Biotech app exactly requires by going through our inventory of:  

Accomplishing forensics, environmental, pharmaceutical applications? Depend on Lab.Equipment to improve your productivity and efficiency. Shop precise and accurate lab equipment for whatever application here.

Back To Top
We are fully compliant with the GDPR laws. We promise to safeguard your data and protect your privacy rights.